EDITORIALS
Rate control for atrial fibrillation: one drug or two?
Correspondence to:
Dr Oliver R Segal, Department of Electrophysiology, The Heart Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK; oliver.segal@uclh.nhs.uk
Keywords: cardiology; adult cardiology; pacing and electrophysiology
| The first 150 words of the full text of this article appear below. |
Rate control for atrial fibrillation has been proven to be a reasonable treatment option for certain groups of patients with persistent or permanent atrial fibrillation.1–5 The mainstays of rate control treatment include β-blockers, calcium channel blockers and digoxin. What is surprising is that despite the existence of these drugs for a considerable time (over 200 years in the case of digoxin), we are still not clear which single drug or combination of drugs is optimal. Doubt arises due to the lack of robust data examining this specific issue in the form of large randomised clinical trials. Despite this lack of evidence, guidelines from the National Institute for Health and Clinical Excellence (NICE)6 and the combined forces of the American Heart Association (AHA), American College of Cardiology (ACC) and the European Society of Cardiology (ESC)7 promote monotherapy using drugs other than digoxin as first line treatment. But what is the basis
Relevant Article
- Chronic atrial fibrillation: a systematic review of medical heart rate control management
- T Nikolaidou, K S Channer
Postgrad. Med. J. 2009 85: 303-312.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
